De Novo device
cNEP Airway
Sommetrics · External Airway (PMB, Class II) · First FDA decision Dec 23, 2015, newest Dec 23, 2015Sleep apnea
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
De Novo pathway
Device trials
9
Naming "cNEP"
MAUDE reports
0
Brand "cNEP", since 2015
PubMed studies
80
Mentioning "cNEP"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing cNEP Airway
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- cNEP AirwayNew device typeDe Novo
DEN140024 · Decided Dec 23, 2015 · 492 days after receipt
Device type: External Airway (PMB) · Anesthesiology & Respiratory
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "cNEP", any status and sponsor, newest update first.
NYU Langone HealthAcademic, hospital or other
NCT05675345 · 20 participants (planned) · Start Feb 28, 2024 · Primary completion Jun 30, 2027
Device: HFNC only; HFNC + CNEP10 and 2 more · For: Acute Hypoxemic Respiratory Failure
Sites: Brooklyn, New York; New York, New York · 4 sites in all
Sommetrics, Inc.Not on our public-company list
NCT02767843 · 4 participants · Start May 2016 · Primary completion Nov 2016
Device: continuous negative external pressure (cNEP) · For: Snoring
Sites: Alameda, California
Sommetrics, Inc.Not on our public-company list
NCT05608486
Device: aerSleep II · For: Obstructive Sleep Apnea; Sleep Apnea
6 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "cNEP", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code PMB
1 reports: 1 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "cNEP"[tiab]. The summary above synthesizes these.
- Lung recruitment by continuous negative extra-thoracic pressure support following one-lung ventilation: an experimental study.
Schranc Á, Diaper J, Südy R, et al. · Front Physiol · 2023
- Mirogabalin for Central Neuropathic Pain After Spinal Cord Injury: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study in Asia.
Ushida T, Katayama Y, Hiasa Y, et al. · Neurology · 2023Randomized Controlled Trial, Clinical Trial, Phase III
- Continuous negative external pressure (cNEP) reduces respiratory impairment during screening colonoscopy: a pilot study.
Kais SS, Klein KB, Rose RM, et al. · Endoscopy · 2016
- The CNEP trial: how a good trial was turned rotten.
Abbasi K · J R Soc Med · 2010Editorial, Introductory Journal Article
- Southall's CNEP trial more than stands up to scrutiny.
The Lancet · Lancet · 2006Editorial, Comment
- The circulating form of neprilysin is not a general biomarker for overall survival in treatment-naïve cancer patients.
Pavo N, Arfsten H, Cho A, et al. · Sci Rep · 2019Research Support, Non-U.S. Gov't
- Modified setting of negative pressure in children with mild respiratory disease.
Ishimori S, Nagase S, Kanagawa A, et al. · Pediatr Int · 2021Observational Study
- Sensory and pain modulation profiles of ongoing central neuropathic extremity pain in multiple sclerosis.
Srotova I, Kocica J, Vollert J, et al. · Eur J Pain · 2021Observational Study, Research Support, Non-U.S. Gov't
- Outcome after neonatal continuous negative-pressure ventilation: follow-up assessment.
Telford K, Waters L, Vyas H, et al. · Lancet · 2006Research Support, Non-U.S. Gov't
- Identification and characterization of constrained non-exonic bases lacking predictive epigenomic and transcription factor binding annotations.
Grujic O, Phung TN, Kwon SB, et al. · Nat Commun · 2020Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Regulated lipid synthesis and LEM2/CHMP7 jointly control nuclear envelope closure.
Penfield L, Shankar R, Szentgyörgyi E, et al. · J Cell Biol · 2020Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Continuous negative extrathoracic pressure or continuous positive airway pressure for acute hypoxemic respiratory failure in children.
Shah PS, Ohlsson A, Shah JP · Cochrane Database Syst Rev · 2005Systematic Review
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.